Abpro Holdings, Inc. Warrant
ABPWW
About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
Employees: 6
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
12% more funds holding
Funds holding: 25 [Q1] → 28 (+3) [Q2]
19% less capital invested
Capital invested by funds: $243K [Q1] → $198K (-$45K) [Q2]
Financial journalist opinion
We haven’t received any recent news articles for ABPWW